NCT03607669View on ClinicalTrials.gov

Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Ischemic CardiomyopathyDilated CardiomyopathyHypertrophic Cardiomyopathy
Interventions
OTHER

Mangafodipir trisodium

Manganese-based MRI contrast agent

Trial Locations (1)

EH16 4TJ

Queen's Medical Research Institute, University of Edinburgh, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT03607669 - Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium | Biotech Hunter | Biotech Hunter